⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6416529 | 0.84 | — | — | |
| SCHEMBL7349463 | 0.82 | KMT2A (0.46) | — | |
| SCHEMBL5362265 | 0.79 | — | — | |
| SCHEMBL8535020 | 0.74 | — | — | |
| SCHEMBL5539783 | 0.73 | CXCR4 (0.36) | — | |
| SCHEMBL6369958 | 0.70 | — | — | |
| SCHEMBL8659221 | 0.70 | ARG1 (0.33) | — | |
| SCHEMBL28101864 | 0.70 | — | — | |
| SCHEMBL17887758 | 0.70 | KMT2A (0.35) | — | |
| SCHEMBL7289311 | 0.69 | CCR2 (0.36) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1050830-C | Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents | SCHERING CORP (US) | 2000-03-29 | — | — | CN | disclosed |
| CN-1131416-A | Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents | SCHERING CORP (US) | 1996-09-18 | — | — | CN | disclosed |